New drug combo tested to protect Kids' hearts from kawasaki disease damage
NCT ID NCT04747847
Summary
This small, early-stage study tested whether a combination of two existing drugs could help children with Kawasaki disease. Kawasaki disease can cause dangerous inflammation in the heart's arteries. The researchers wanted to see if using atorvastatin (a cholesterol drug) and anakinra (an anti-inflammatory drug) together was safe and could reduce this inflammation to prevent long-term heart damage.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KAWASAKI DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California San Diego
San Diego, California, 92093, United States
Conditions
Explore the condition pages connected to this study.